The head of the group, which is leading efforts to combat the epidemic in the government, said the United States hopes to launch a vaccine program against covid-19 in early December.
“Our plan is to be able to ship vaccines to vaccine locations within 24 hours after they are approved by the Food and Drug Administration (FDA),” Moncef Slaoui told CNN.
According to reports, FDA consultants will meet on 8-10 December to discuss the approval of the vaccines that Pfizer and Moderna say are at least 95% effective.
The senior official also said he hopes the country will achieve “herd immunity” in May when the mass vaccination campaign is launched.
“Normally, with the level of effectiveness we have (95%), vaccinating about 70% of the population will give you a real pack of immunity. Probably something like this will happen in May or depending on our plans. “Said.
“I really hope that the negative perception level of the vaccine will decrease and people’s acceptance will increase. This will be very important to help us, ”he insisted, pointing to the mistrust of many people about the vaccine.
This demand was expected for a few days after the results of the clinical trial that had been conducted among 44,000 volunteers in various countries since July and that the vaccine would be 95% effective against covid-19 without serious side effects.
The US agency announced that a public meeting of the vaccine advisory committee will be held on December 10 to consider the application.
The opinion of this committee is advisory. The decision whether to authorize the vaccine will be up to FDA scientists and can be taken as early as the first half of December.
The Trump administration plans to vaccinate 20 million people at risk in December, after 25 to 30 million per month.
The United States is the absolute hardest hit country with the virus, exceeding the threshold of 12 million cases and more than 255,000 deaths.